STOCK TITAN

Equus Announces Fourth Quarter Net Asset Value

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Equus Total Return (NYSE: EQS) reported net assets of $16.6 million and net asset value per share of $1.19 as of December 31, 2025, down from $26.5 million and $1.90 per share on September 30, 2025.

Primary drivers: a $12.35 million decrease in the fair value of Morgan E&P and a $1.6 million increase in the combined value of CitroTech shares and warrant to $6.8 million.

Loading...
Loading translation...

AI-generated analysis. Not financial advice.

Positive

  • CitroTech fair value increased by $1.6 million in Q4 2025
  • CITR Note converted into 664,041 CitroTech shares, reducing debt exposure
  • CITR holdings valued at $6.8 million as of 12/31/2025

Negative

  • Net assets fell from $26.5M to $16.57M quarter-over-quarter
  • NAV per share declined from $1.90 to $1.19 between 9/30/2025 and 12/31/2025
  • Morgan E&P fair value decreased by $12.35M due to oil forward curve and reserve elimination

News Market Reaction – EQS

-1.46%
1 alert
-1.46% News Effect

On the day this news was published, EQS declined 1.46%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

Net assets: $16.6 million NAV per share: $1.19 Net assets per share trail: $1.19 / $1.90 / $2.51 / $2.52 / $2.17 +5 more
8 metrics
Net assets $16.6 million As of December 31, 2025
NAV per share $1.19 As of December 31, 2025 (down from $1.90 on September 30, 2025)
Net assets per share trail $1.19 / $1.90 / $2.51 / $2.52 / $2.17 Quarterly NAV per share from 12/31/2025 back to 12/31/2024
Morgan fair value change $12.35 million decrease Holding in Morgan E&P between September 30 and December 31, 2025
CITR note principal $1.5 million 1-year senior convertible promissory note purchased February 10, 2025
CITR coupon rate 10% per annum Interest rate on CITR convertible promissory note
CITR equity position 664,041 shares (73,002 sold) Shares received on conversion of CITR Note during 2025
CITR fair value gain $1.6 million increase CITR shares and warrant valuation from $5.2M to $6.8M in Q4 2025

Market Reality Check

Price: $1.5300 Vol: Volume 4,851 is at 0.53x ...
low vol
$1.5300 Last Close
Volume Volume 4,851 is at 0.53x the 20-day average of 9,192, indicating muted trading ahead of this NAV update. low
Technical Shares at $1.37 are trading below the $1.72 200-day moving average and 44.98% under the 52-week high of $2.49.

Peers on Argus

EQS slipped 0.72% while peers were mixed: ICMB gained 6.35%, CUBA and GROW fell,...

EQS slipped 0.72% while peers were mixed: ICMB gained 6.35%, CUBA and GROW fell, and BCG and RAND were flat. With no peers in the momentum scanner and no same-day peer headlines, this points to stock-specific reaction around Equus’s NAV deterioration.

Historical Context

1 past event · Latest: Nov 24 (Negative)
Pattern 1 events
Date Event Sentiment Move Catalyst
Nov 24 Quarterly NAV update Negative -4.2% Reported NAV per share drop from $2.51 to $1.90 with fair-value losses.
Pattern Detected

Recent NAV reports have coincided with declines in both net asset value and share price, suggesting sensitivity to portfolio write-downs.

Recent Company History

In the prior NAV update on Nov 24, 2025, Equus reported net assets of $26.5 million and NAV per share of $1.90, down from $2.51 at June 30, 2025. That decline was driven by a $5.4 million fair-value drop in holdings purchased from General Enterprise Ventures and a $1.7 million warrant liability, and the stock fell 4.15% over the next 24 hours. Today’s article extends this narrative, with NAV per share sliding further to $1.19 as of December 31, 2025, highlighting additional portfolio volatility.

Market Pulse Summary

This announcement details a further drop in net assets to $16.6 million and NAV per share to $1.19 a...
Analysis

This announcement details a further drop in net assets to $16.6 million and NAV per share to $1.19 as of December 31, 2025, extending declines from prior quarters. The main drag was a $12.35 million fair-value reduction in Morgan E&P, while CITR holdings added a $1.6 million gain. Investors may compare this trajectory to earlier NAV updates and monitor how concentrated energy and illiquid positions continue to affect valuation and capital allocation decisions.

Key Terms

net asset value, fair value, convertible promissory note, common stock purchase warrant, +1 more
5 terms
net asset value financial
"Equus Announces Fourth Quarter Net Asset Value"
Net asset value is the total value of an investment fund's assets minus any liabilities, divided by the number of shares or units outstanding. It represents the per-share worth of the fund, similar to how the value of a house is determined by its total worth after debts are subtracted. Investors use it to gauge the true value of their holdings and to compare different investment options.
fair value financial
"The following were the principal contributors to changes in the net asset value..."
Fair value is an estimate of what an asset or company is really worth today, derived from expected future earnings, comparable market prices and other relevant facts—like agreeing a price for a used car after checking mileage, condition and similar listings. Investors use fair value to decide whether a stock looks overpriced or undervalued, which helps guide buy, hold or sell decisions and sets expectations for potential returns and risk.
convertible promissory note financial
"a 1-year senior convertible promissory note bearing interest at the rate of 10% per annum"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
common stock purchase warrant financial
"received a 5-year common stock purchase warrant to acquire an aggregate of 312,500 shares"
A common stock purchase warrant is a tradable certificate that gives its holder the right to buy a company’s common shares at a fixed price for a set period. Think of it as a coupon that lets you buy stock later at today’s agreed price; it can amplify gains if the share price rises but also can increase the total number of shares outstanding, which may reduce existing owners’ percentage of the company. Investors watch warrants because they offer leveraged upside and can affect future share value and ownership.
exercise price financial
"CITR Warrant at an exercise price of $3.00 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

AI-generated analysis. Not financial advice.

HOUSTON, April 21, 2026 (GLOBE NEWSWIRE) -- Equus Total Return, Inc. (NYSE: EQS(“Equus” or the “Company”) reports net assets as of December 31, 2025, of $16.6 million. Net asset value per share decreased to $1.19 as of December 31, 2025, from $1.90 as of September 30, 2025. Comparative data is summarized below (in thousands, except per share amounts):

As of the Quarter Ended12/31/20259/30/20256/30/20253/31/202512/31/2024

Net assets$16,570$26,504$34,111$34,197$29,510
Shares outstanding13,96713,96713,58613,58613,586
Net assets per share$1.19$1.90$2.51$2.52$2.17
      

Net Asset Value Changes. The following were the principal contributors to changes in the net asset value of the Company in the fourth quarter of 2025:

  • Decrease in Fair Value of Morgan E&P, Inc. Morgan E&P, Inc. (“Morgan”) holds development rights to approximately 6,500 net acres in the Bakken/Three Forks formation in the Williston Basin of North Dakota. Principally due to a lower forward price curve for oil (as of December 31, 2025) as well as the elimination of certain reserves due to limited production, the value of the Company’s holding in Morgan decreased by $12.35 million at December 31, 2025, compared to September 30, 2025.
  • Increase in Fair Value of Holdings in CitroTech, Inc. On February 10, 2025, the Company purchased from CitroTech, Inc. (formerly General Enterprise Ventures, Inc.), a developer of fire suppression products (NYSE: CITR), a 1-year senior convertible promissory note bearing interest at the rate of 10% per annum, in exchange for $1.5 million in cash (“CITR Note”). Contemporaneously with the purchase of the CITR Note, the Company also received a 5-year common stock purchase warrant to acquire an aggregate of 312,500 shares of CITR common stock at an exercise price of $3.00 per share (“CITR Warrant”). During 2025, the CITR Note was converted by the Company into 664,041 shares of CITR common stock, of which 73,002 shares were sold by the Company. During the fourth quarter of 2025, the trading price of CITR shares increased from $5.89 per share to $8.08 per share. At December 31, 2025, the Company collectively valued the CITR shares and CITR Warrant at an aggregate of $6.8 million as compared to $5.2 million at September 30, 2025, an increase of $1.6 million.

About Equus

The Company is a business development company that trades as a closed-end fund on the New York Stock Exchange under the symbol "EQS". Additional information on the Company may be obtained from the Company’s website at www.equuscap.com.

This press release may contain certain forward-looking statements regarding future circumstances. These forward-looking statements are based upon the Company’s current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements including, in particular, the performance of the Company, including our ability to achieve our expected financial and business objectives, and the other risks and uncertainties described in the Company’s filings with the SEC. Actual results, events, and performance may differ. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as to the date hereof. Except as required by law, the Company undertakes no obligation to release publicly any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. The inclusion of any statement in this release does not constitute an admission by the Company or any other person that the events or circumstances described in such statements are material.

Contact:

Equus Total Return, Inc.
1-888-323-4533


FAQ

Why did EQS report a lower NAV per share on April 21, 2026?

The NAV per share fell to $1.19 primarily due to a $12.35 million fair-value decline in Morgan E&P. According to the company, a lower oil forward price curve and elimination of certain reserves drove the Morgan valuation drop, reducing overall net assets.

How much did Equus value its holdings in CitroTech (NYSE: CITR) at December 31, 2025?

Equus valued its CitroTech shares and warrant at $6.8 million as of 12/31/2025. According to the company, that was up $1.6 million from $5.2 million at 9/30/2025 following share price appreciation and prior note conversion.

What change occurred to the CITR Note held by Equus during 2025?

The company converted the $1.5 million CITR senior convertible note into 664,041 CitroTech shares during 2025. According to the company, 73,002 of those shares were sold and a 5-year warrant remains as part of the position.

How large was Equus's net asset decline in dollar terms for Q4 2025?

Net assets decreased from $26.5 million to $16.57 million quarter-over-quarter. According to the company, the net asset decline principally reflects the $12.35 million reduction in the Morgan E&P fair value offset partly by CitroTech gains.

How many shares were outstanding for EQS at December 31, 2025?

Equus had 13,967 shares outstanding at 12/31/2025. According to the company, share count was unchanged from 9/30/2025 and is reported alongside net assets and NAV per share in the quarter comparison.